Biosurgery Market Analysis & Forecast 2024-2030

Global Biosurgery Market is expected to reach USD 22601.25 million by 2031 with CAGR of 6.4 % between 2025 and 2031

Overview

Biosurgery is a branch of surgery that works on decreasing Intra and post-surgical procedural complications such as blood loss during the surgical process. The biosurgery uses bio-based such as surgical sealants, absorbable hemostats, absorbable sutures, absorbable gelatine sponges, etc. Nowadays biosurgery procedures are widely practised in developed countries in a range of surgical procedures including neurological surgeries, orthopedic surgeries, thoracic surgeries, cardiovascular surgeries, urology surgeries as well as common surgical procedures.  

Rising demand for minimally invasive surgical procedures, the increasing ageing population, the prevalence of chronic medical conditions, and growing technological advancements in biosurgery products are some factors driving the growth of the Global Biosurgery Market. However, high costs and contradictions over the safety and reliability of procedures are restraining the growth of the market. Ongoing technological advancements in biologics will offer lucrative opportunities for the growth of the market in the forecast period .  

Product types & Competitive analysis

Based on product type, the Global Biosurgery Market is segmented into surgical sealants, hemostatic agents, adhesion barriers, bone graft substitutes, and staple line reinforcement agents. The surgical sealants segment accounted for a major revenue share in 2024. The growth of the segment was primarily due to a rise in physical traumas, the prevalence of chronic diseases, and medical conditions that require a surgical procedure. Hemostatic agents and adhesion barrier biosurgery products were the fastest-growing segments and are projected to grow at the highest CAGR in the forecast period .  

Competitive analysis included in research study helps users to understand key players market positioning and marketing strategies. Global Biosurgery market is witnessing growth due to continuous research and development in the area of genomics and proteomics which is expected to yield new, more sophisticated and specialized diagnostic tests. The market is witnessing increased competition from international players and private hospital chains which are investing in their own diagnostic capabilities. Small players do not have the deep pockets to invest in research and development like larger companies which makes them potential acquisition targets and drives industry consolidation.  

 

Application & Regional analysis

On the basis of applications, the Global Biosurgery Market is categorized into neurological surgeries, cardiovascular surgeries, general surgeries, orthopedic surgeries, thoracic surgeries, gynecology surgeries, urology surgeries, and reconstructive surgeries. The general surgeries segment accounted for the largest revenue in 2024. General surgery care help in treating wide range of diseases and health conditions. General surgery care is one of the important sectors in healthcare that assist in performing a number of biosurgery procedures ranging from treatment of traumatic injuries to the treatment of chronic diseases such as osteoarthritis and bowel disorders. Rising volumes of surgical procedures, and developing surgical care across the world are expected to fuel the growth of the general surgery segment in the forecast period. The orthopedic surgeries segment was the fastest-growing segment in 2024 and is projected to grow at the highest CAGR in the forecast period .  

 

Regional outlook of research study is based on analysis of the market in North America, Europe, Asia Pacific, Middle East, South America, Africa & Rest of the World. North America led the growth of the Global Biosurgery Market in 2024 and is expected to maintain its dominance in the forecast period. The growth in the region was attributed to the rising number of biosurgery procedures in the US and Canada. According to Healthgrades in the U.S., more than a million people undergo joint replacement surgery each year which is around 330,000 hip replacements and 720,000 knee replacements. In addition, rising prevalence of chronic diseases, sports injuries, morbid obesity, and the presence of sophisticated healthcare infrastructure will boost the growth of the biosurgery market in the North American region in the coming years.  

Europe is the second-largest region in terms of revenue generation followed by the Asia Pacific. The presence of key players in biosurgery consumables, upsurge in surgical interventions to treat chronic health conditions, and rising prevalence of obesity in the region are driving the growth of the European biosurgery market. The rising geriatric population in Europe has given rise to a number of serious health conditions. According to the European Chronic Disease Alliance, over 100 million citizens in Europe above the age of 15 suffer from a chronic disease and two out of three persons who have reached retirement age, have at least two chronic health conditions. The Asia Pacific is expected to witness the fastest growth in the forecast period owing to the rising prevalence of chronic diseases, geriatric population, and volume of surgical interventions. China has been a major player in the region in terms of volume of surgical procedures and is projected to grow at a significant share in the forecast period.  

 

Global Biosurgery Market : Product Types

• Surgical sealants
• Hemostatic agents
• Bone graft substitutes
• Staple line reinforcement agents

Global Biosurgery Market : Application

• Neurological surgeries
• Cardiovascular surgeries
• Orthopedic surgeries
• Thoracic surgeries
• Gynecology surgeries
• Urology surgeries
• Reconstructive surgeries

Global Biosurgery Market : Competitive Analysis

Report includes an accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study consists of the following key players in Global Biosurgery Market :

• Johnson & Johnson
• Baxter International Inc
• Medtronic
• Stryker Corp.
• Pfizer Inc.
• Smiths & Nephew
• Meril Lifesciences

Geographical analysis of Global Biosurgery Market :

• North America
  • U.S.A
  • Canada
• Europe
  • France
  • Germany
  • Spain
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South East Asia
• Latin America
  • Brazil
• Middle East and Africa

Global Biosurgery Market Report delivers a comprehensive analysis of the following parameters:

• Market Forecast for 2024-2030
• Market growth drivers
• Challenges and Opportunities
• Emerging and Current market trends
• Market player Capacity, Production, Revenue (Value)
• Supply (Production), Consumption, Export, Import analysis
• End user/application Analysis

---

Frequently Asked Questions (FAQ)